We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+17.89%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$7.41B
AUM Growth
+$1.13B
Cap. Flow
+$113M
Cap. Flow %
1.53%
Top 10 Hldgs %
20.78%
Holding
371
New
22
Increased
164
Reduced
130
Closed
11

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$33.5M
2
INTC icon
Intel
INTC
+$28.4M
3
HD icon
Home Depot
HD
+$24.6M
4
HMSY
HMS Holdings Corp.
HMSY
+$17.6M
5
ICUI icon
ICU Medical
ICUI
+$16.4M

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$25.4M
2
CLX icon
Clorox
CLX
+$19.6M
3
DHR icon
Danaher
DHR
+$18.4M
4
CBSH icon
Commerce Bancshares
CBSH
+$16M
5
BKNG icon
Booking.com
BKNG
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Healthcare 15.68%
3 Industrials 14.62%
4 Financials 13.46%
5 Consumer Discretionary 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
301
Mondelez International
MDLZ
$79.5B
$643K 0.01%
12,578
BSV icon
302
Vanguard Short-Term Bond ETF
BSV
$44.7B
$628K 0.01%
7,550
LHX icon
303
L3Harris
LHX
$51.6B
$626K 0.01%
3,691
UL icon
304
Unilever
UL
$137B
$625K 0.01%
10,124
NVO
305
Novo Nordisk
NVO
$208B
$567K 0.01%
17,330
BAX icon
306
Baxter International
BAX
$13.5B
$560K 0.01%
6,500
+699
+12% +$60.9K
IWB icon
307
iShares Russell 1000 ETF
IWB
$48.2B
$555K 0.01%
3,232
VO icon
308
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$511K 0.01%
12,476
VEA icon
309
Vanguard FTSE Developed Markets ETF
VEA
$229B
$505K 0.01%
13,031
-767
-6% -$28K
CVS icon
310
CVS Health
CVS
$133B
$503K 0.01%
7,747
AVGO icon
311
Broadcom
AVGO
$1.85T
$497K 0.01%
15,750
VCLT icon
312
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$489K 0.01%
4,600
WBA
313
DELISTED
Walgreens Boots Alliance
WBA
$482K 0.01%
11,362
-4,300
-27% -$183K
NOC icon
314
Northrop Grumman
NOC
$77.1B
$475K 0.01%
1,546
-7
-0.5% -$2.29K
WMT icon
315
Walmart Inc
WMT
$885B
$474K 0.01%
11,874
SO icon
316
Southern Company
SO
$109B
$471K 0.01%
9,079
GE icon
317
GE Aerospace
GE
$374B
$443K 0.01%
13,028
-2,621
-17% -$88.4K
VRTX icon
318
Vertex Pharmaceuticals
VRTX
$121B
$438K 0.01%
1,508
EWJ icon
319
iShares MSCI Japan ETF
EWJ
$21.9B
$437K 0.01%
7,950
+250
+3% +$13.3K
QUAL icon
320
iShares MSCI USA Quality Factor ETF
QUAL
$46.4B
$434K 0.01%
4,527
APA icon
321
APA Corp
APA
$13.2B
$432K 0.01%
32,000
-11,861
-27% -$135K
ILMN icon
322
Illumina
ILMN
$31B
$429K 0.01%
+1,190
New +$383K
BSX icon
323
Boston Scientific
BSX
$69.5B
$427K 0.01%
12,149
DFS
324
DELISTED
Discover Financial Services
DFS
$417K 0.01%
8,321
-118,840
-93% -$5.23M
K
325
DELISTED
Kellanova
K
$391K 0.01%
6,310

Similar funds

Boston Trust Walden's Q2 2020 Portfolio in Review

As of Q2 2020, Boston Trust Walden held 371 positions worth $7.41B, up 18% from $6.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Trust Walden's Q2 2020 filing shows 22 new, 164 increased, 130 reduced and 11 closed positions. Its largest new stake was Medpace: 393,535 shares worth $36.6M. The largest sale was Sysco, an estimated $25.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Trust Walden's largest Q2 2020 buy was Medpace: 393,535 shares worth $36.6M.
  • Boston Trust Walden added most to Intel in Q2 2020, an estimated $28.4M increase.
  • Boston Trust Walden's biggest Q2 2020 reduction was Sysco, cutting an estimated $25.4M.
  • Boston Trust Walden fully exited Booking.com in Q2 2020, selling an estimated $15.1M.
  • Boston Trust Walden's ten largest holdings make up 21% of its $7.41B portfolio in Q2 2020.
  • Boston Trust Walden opened 22 new positions and closed 11 in Q2 2020.
  • Boston Trust Walden's portfolio value rose 18% quarter-over-quarter to $7.41B.

Based on Boston Trust Walden's 13F filing for Q2 2020, filed 23 Jul 2020.